Perforin is expressed in CTL populations generated in vivo

Area of Science:

• Immunology
• Cancer Research
• Cellular Biology

Background:

• Syngeneic tumor immunization can induce adaptive immune responses.
• Cytotoxic T lymphocytes (CTLs) play a crucial role in tumor immunosurveillance.
• Understanding the mechanisms of CTL activation and function is vital for cancer immunotherapy.

Purpose of the Study:

• To investigate the characteristics of in vivo-generated anti-tumor effector cells.
• To determine the phenotype and cytotoxic mechanisms of CTLs induced by syngeneic tumor immunization.
• To provide evidence for perforin expression in CD8+ CTLs generated against syngeneic tumors.

Main Methods:

• Immunization of C57BL/6 mice with syngeneic MBL-2 lymphoma cells.
• Isolation and characterization of peritoneal exudate cells (PEC).
• Assessment of specific cytotoxicity against tumor cell lines.
• Flow cytometry (FACStar) for T cell receptor (TCR) and CD8+ T cell identification.
• Immunohistochemistry and electron microscopy for perforin localization.

Main Results:

• Mice immunized with MBL-2 cells rejected subsequent MBL-2 challenge but not B16 melanoma.
• Peritoneal cells from immunized mice contained CTLs specifically cytotoxic to MBL-2 cells.
• The identified CTLs were characterized as TCR alpha beta+ CD8+ T cells.
• Electron microscopy confirmed the presence of perforin within cytoplasmic granules of these CTLs.
• This study provides the first evidence of significant perforin expression in CD8+ CTLs induced against syngeneic tumors in vivo.

Conclusions:

• In vivo immunization with syngeneic tumor cells effectively generates antigen-specific CD8+ cytotoxic T lymphocytes.
• These CD8+ CTLs utilize the perforin-mediated cytotoxic pathway for tumor cell killing.
• The findings highlight the potential of inducing perforin-expressing CD8+ CTLs for anti-cancer strategies.